Thursday, December 24, 2015 6:44:00 AM
And if you notice, XTRN and XREE share the same corporate address and the listed CEO of XREE is the old CEO of XTRN. Wayne Bailey is the new CEO of XREE, he was the CFO, as stated in the 12/3 PR. But no question its the same company, just a different ticker and improved balance sheet and they are flip flopping director titles.
XREE has a better balance sheet w/ $1.4 million in assets and $1.9 million in liabilities but remember someone has to take on the $7 million in liabilities from XTRN. Their current o/s is almost 7 million shares and the float is 1,257,571 shares as indicated in the 9/30/15 disclosure statement.
Only trading activity this company has ever seen is in the last week. Someone dumped 88,000 shares of which it looks like 40k shares have been flipped higher. There's only been 391 shares shorted in the last 30 days, so either a note is converting or an insider is trying to create a more liquid market. But yes, NITE is on the bid obviously ready to short anything he gets his paws on.
The actual transaction isn't disclosed but it might be an attempt on Michael Barron's behalf to get the $25 million investment capital to finally get the company off the ground. They supposedly have a deal to refurbish rail cars for Amtrak subcontractors but its contingent on obtaining the investment capital.
Can't deny something is in the works, they just spent a bundle bringing XREE current so it should be interesting to watch it unfold, especially after XTRN left a nasty taste in many shareholders mouths.
All my posts and information are based on my own research, opinion, and may contain forward looking statements that may never materialize. Always consult a licensed professional for investment advice when choosing an investment as I am not one!
Recent MAPT News
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 02/20/2024 11:03:44 AM
- Form 1-A - Offering Statement [Regulation A] • Edgar (US Regulatory) • 01/04/2024 10:12:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/27/2023 05:23:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 03:53:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 06:05:38 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM